Cormorant Asset Management’s Rockwell Medical RMTI Stock Holding History

Cormorant Asset Management’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,045	Closed	-$8.3M	–	88
2016 Q1	$8.3M	Hold	10,045	–	–	1.25%	28
2015 Q4	$11.3M	Hold	10,045	–	–	1.35%	28
2015 Q3	$8.52M	Buy	10,045 +6,954	+225%	+$10.1M	1.36%	27
2015 Q2	$5.48M	Hold	3,091	–	–	0.73%	40
2015 Q1	$3.72M	Sell	3,091 -545	-15%	-$638K	0.57%	48
2014 Q4	$4.11M	Hold	3,636	–	–	0.63%	40
2014 Q3	$3.66M	Hold	3,636	–	–	0.75%	36
2014 Q2	$4.8M	Hold	3,636	–	–	1.27%	30
2014 Q1	$5.06M	Buy	+3,636	New	+$4.73M	1.16%	32

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Cormorant Asset Management's RMTI Position: Q2 2016 in Review

Cormorant Asset Management sold out of Rockwell Medical (RMTI) in Q2 2016, closing a stake of 10,045 shares — an estimated $8.3M sold.

Cormorant Asset Management first reported a position in RMTI in Q1 2014 and held it in 9 quarters. The position peaked at $11.3M in Q4 2015. 96 funds tracked by Wall St. Rank hold RMTI as of Q2 2016.

Cormorant Asset Management reported no remaining Rockwell Medical position as of Q2 2016 after selling out during the quarter.
Cormorant Asset Management sold 10,045 Rockwell Medical shares in Q2 2016, an estimated $8.3M.
Cormorant Asset Management first reported a position in Rockwell Medical in Q1 2014 and held it in 9 quarters.
Cormorant Asset Management's Rockwell Medical position peaked at $11.3M in Q4 2015.
96 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.